Fellowship trained in both colon and rectal surgery, Dr. Somerville has been in practice since 2005. He specializes in colorectal cancer, diverticular disease and IBD, and is an advanced laparoscopic/minimally invasive surgeon with extensive experience treating a broad range of anorectal diseases, as well. www.somsurgery.com. Dr. Somerville is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, Bladder Reconstruction, and Small Bowel Resection.

"A colorectal surgeon, Dr. Bafford specializes in the treatment of colorectal cancer, inflammatory bowel disease, and benign diseases of the colon, rectum and anus. ""These diseases are very treatable. The surgeries I perform are effective at curing cancer or treating colitis, which allows my patients back to the quality of life they want to have. It's very rewarding to see that type of recovery with so many of my patients,"" she says. Dr. Bafford's special interests include laparoscopic and robotic minimally invasive surgery, approaches that are associated with less pain and a faster recovery. Treatments she offers include surgical treatment of inflammatory bowel disease, sphincter-sparing surgery and organ preservation for rectal cancer, surgery for anorectal disorders, minimally invasive surgery for diverticulitis, treatment of rectal prolapse, and screening and therapeutic colonoscopy. Dr. Bafford has authored or co-authored numerous publications in leading peer-reviewed scientific journals and textbooks. Her research interests are in the pathophysiology of colorectal cancer, disparities in colorectal surgery and the surgical management of inflammatory bowel disease. Her passion and dedication have earned her a consistent spot on Baltimore magazine's ""Top Doctor"" lists for colon and rectal surgery. Videos Andrea Chao Bafford M.D.Colorectal Surgeon Research Summary Dr. Bafford's research has largely focused on IBD. Utilizing institutional databases and the NSQIP IBD, she has investigated perioperative outcomes in IBD patients as they relate to sex, immunosuppressive medical therapy, trauma, preoperative drainage of abscesses, and fecal diversion. She has also published on the microbiota of perianal Crohn’s disease with the help of an intramural grant. In addition, through interdepartmental collaboration, Dr. Bafford has contributed towards intestinal organoid preparation and 3D colon cancer organoid development used to study immune responses to intestinal infections, intestinal immunity, and colon cancer pathogenesis.". Dr. Bafford is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. Her top areas of expertise are Crohn's Disease, Ulcerative Colitis, Familial Colorectal Cancer, Hernia Surgery, and Ileostomy.

Dr. Shin specializes Barrett's esophagus, pancreatobiliary disease (pancreatic cyst, family history of pancreatic cancer), GI malignancy, and advanced endoscopy, including endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS). Dr. Shin is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Bile Duct Stricture, Endoscopy, and Pancreaticoduodenectomy.

Irina Bernescu is a Colorectal Surgeon in Columbia, Maryland. Dr. Bernescu is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. Her top areas of expertise are Anal Cancer, Familial Colorectal Cancer, Hemorrhoids, Hernia Surgery, and Colonoscopy.

Dan Kunaprayoon is a Radiation Oncologist in Columbia, Maryland. Dr. Kunaprayoon is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Breast Cancer, and Pleuropulmonary Blastoma.

Arvinder Uppal is a Radiologist in Columbia, Maryland. Dr. Uppal is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. Her top areas of expertise are Tenosynovitis, Progressive Familial Intrahepatic Cholestasis Type 1, Progressive Familial Intrahepatic Cholestasis Type 2, and Progressive Familial Intrahepatic Cholestasis Type 3.

Dung Le, M.D. is a professor of oncology at the Johns Hopkins University School of Medicine and member of the Johns Hopkins Kimmel Cancer Center. Her research interests include novel approaches to patients with gastrointestinal malignancies. She has served as the principal investigator (PI) on many clinical trials focused on testing immunotherapy in patients with gastrointestinal malignancies and she has also served as the national PI on several studies including: anti-programmed death-1 (PD-1) in tumors with mismatch repair deficiency; a clinical trial in advanced pancreatic cancer patients evaluating the safety, tolerability and immune response to CRS-207, a listeria vaccine platform which has been modified to express the tumor antigen mesothelin; a multi-center, phase 2 study testing CRS-207 as a boost to allogenic pancreatic tumor cells transfected with GM-CSF gene (GVAX) for treatment of advanced pancreatic adenocarcinoma (PDA); a trial testing GVAX/ipilimumab in the maintenance setting for metastatic pancreatic cancer; and GVAX/CRS-207 +/- nivolumab in metastatic pancreatic cancer. These studies incorporate extensive laboratory correlates and have involved collaborations with clinicians and bench scientists with expertise in the fields of immunotherapy and cancer genomics. Dr. Le is rated as a Distinguished provider by MediFind in the treatment of Gastroesophageal Junction Cancer. Her top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Gastroesophageal Junction Cancer, and Familial Pancreatic Cancer.

Dr. Nilofer S. Azad is Professor of Oncology at Johns Hopkins University School of Medicine and serves as the Associate Cancer Center Director for Clinical Research for the Johns Hopkins Sidney Kimmel Cancer Center. Dr. Azad earned her medical degree and completed a residency in internal medicine at Baylor College of Medicine in Houston, Texas. She then completed a fellowship in oncology and hematology at the National Institute of Health's National Cancer Institute in Bethesda, Maryland where she served as chief fellow. Dr. Azad’s research focused on early phase drug development and the intersection of moving exciting laboratory findings into patients for new treatment options Dr. Azad joined the faculty at the Kimmel Cancer Center in 2008. Dr. Azad’s clinical expertise is in cancers of the gastrointestinal tract, with a concentration in colorectal cancer, cholangiocarcinoma and pancreaticobiliary tract cancer. Her research efforts are dedicated to developing new drug combinations for patients with advanced cancer. In particular, Dr. Azad’s laboratory and clinical trials explore epigenetic therapy in combination with chemotherapy and immunotherapy to improve survival for patients, as well as molecularly targeted drugs. She is an active clinical trialist, leading multiple clinical trials of molecularly targeted agents for advanced cancer patients. Dr. Azad has received numerous grants for her work from entities such as the NCI (National Cancer Center), American Cancer Society, American Society of Clinical Research, Breakthrough Cancer Foundation, the Lustgarten Foundation, The Gateway Foundation, and the National Comprehensive Cancer Network, among others. She served as Principal for Johns Hopkins on the AACR Stand Up 2 Cancer Colorectal Cancer Dream Team and is a member of the Stand Up 2 Cancer Epigenetics Dream Team, leading the GI cancer initiatives for the group. Dr. Azad is a national leader in GI cancer, including serving as a member of the national NCI Colon Cancer Task Force and as Co-Chair of the Scientific and Medical Advisory Board for the Cholangiocarcinoma Foundation. She has a presidential appointment to the National Cancer Advisory Board. Dr. Azad is rated as a Distinguished provider by MediFind in the treatment of Gastroesophageal Junction Cancer. Her top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Hepato-Pancreato-Biliary Surgery, and Colonoscopy.

Dr. John Migaly is a distinguished colorectal surgeon and Chief of the Division of Colorectal Surgery/Ravitch Division at Johns Hopkins Medicine. He specializes in the treatment of colorectal cancer, inflammatory bowel disease, and other benign and complex colorectal conditions. Dr. Migaly is committed to providing advanced, patient-centered care, often using minimally invasive techniques including laparoscopic and robotic surgery, to help reduce recovery time and improve outcomes. Dr. Migaly comes to Johns Hopkins Medicine from the Duke University School of Medicine, serving from 2008-2024 on the surgery faculty treating patients primarily through the Duke Cancer Institute. He was elevated to Program Director of the General Surgery Residency in 2012, and subsequently served as Vice Chair of Education until 2024. His work was critical to the success of the undergraduate, graduate, and continuing medical education missions at Duke Surgery. Dr. Migaly earned his B.A. in Biochemistry from New York University and his medical degree from the New York University School of Medicine. He completed surgical residency and a research fellowship at Temple University Health Sciences Center, and colorectal surgery fellowship at Cleveland Clinic Florida. Dr. Migaly’s career has been marked not only by a complex and high-volume clinical colon and rectal surgery practice, but also a commitment to research and education, supported by greater than 200 publications, book chapters, and presentations. His research is centered around improving practice patterns and outcomes in colorectal cancer care and recovery. His leadership and dedication to advancing the field of colorectal surgery is evident through his service on committees that shape how colorectal care is delivered nationally, via his past and present service on the Program Committee, the Clinical Practice Guidelines Committee and the Diversity and Inclusion Committee of the American Society of Colon and Rectal Surgeons. Videos John Migaly, M.D.Chief of Colorectal Surgery"". Dr. Migaly is rated as a Distinguished provider by MediFind in the treatment of Gastroesophageal Junction Cancer. His top areas of expertise are Familial Colorectal Cancer, Gastroesophageal Junction Cancer, Anal Cancer, Colostomy, and Ileostomy.

Ilene S. Browner, M.D. specializes in geriatric oncology. Dr. Browner is rated as a Distinguished provider by MediFind in the treatment of Gastroesophageal Junction Cancer. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Endoscopy.

Stuart Selonick is a Hematologist Oncology specialist and a Hematologist in Columbia, Maryland. Dr. Selonick is rated as an Advanced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Idiopathic Neutropenia, and Lung Cancer. Dr. Selonick is currently accepting new patients.

Rachel Klein is a Nurse Practitioner in Columbia, Maryland. Ms. Klein is rated as an Advanced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. Her top areas of expertise are Gastroesophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma, Ampullary Cancer, and Gallbladder Adenocarcinoma.

James Zalucki is a Colorectal Surgeon in Ellicott City, Maryland. Dr. Zalucki is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. His top areas of expertise are Hemorrhoids, Mesenteric Venous Thrombosis, Proctitis, Ureteroscopy, and Hernia Surgery.

Thomas Abernathy is a Gastroenterologist in Catonsville, Maryland. Dr. Abernathy is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. His top areas of expertise are Lactose Intolerance, Familial Adenomatous Polyposis, Hemorrhoids, Gastrectomy, and Colonoscopy.

Rita Gupta is a Hematologist Oncology specialist and a Hematologist in Columbia, Maryland. Dr. Gupta is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. Her top areas of expertise are Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Paget Disease of the Breast, and Breast Cancer. Dr. Gupta is currently accepting new patients.

Jose Mendoza is a Hematologist Oncology specialist and a Hematologist in Columbia, Maryland. Dr. Mendoza is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Anemia, and Familial Colorectal Cancer. Dr. Mendoza is currently accepting new patients.

Jason Taksey is an Oncologist and a Hematologist in Columbia, Maryland. Dr. Taksey is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. His top areas of expertise are Urothelial Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, and WT1-Related Wilms Tumor Syndromes. Dr. Taksey is currently accepting new patients.

Nicholas Demonaco is a Hematologist Oncology specialist and a Hematologist in Columbia, Maryland. Dr. Demonaco is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. His top areas of expertise are Pulmonary Embolism, Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, and Anemia. Dr. Demonaco is currently accepting new patients.

Peter Graze is a Hematologist Oncology specialist and a Hematologist in Columbia, Maryland. Dr. Graze is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Non-Small Cell Lung Cancer (NSCLC). Dr. Graze is currently accepting new patients.

Suzan Abdo is a primary care provider, a Geriatrics specialist and a General Practice provider in Columbia, Maryland. Dr. Abdo is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. Her top areas of expertise are Familial Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia (HeFH), Hyperlipoproteinemia Type 4, and Defective Apolipoprotein B-100. Dr. Abdo is currently accepting new patients.